Radiation planning after sinus surgery using dose painting
Part of Cancer clinical trials.
This trial tests a specialized way of planning radiation (“dose painting”) for people with cancer of the sinuses after they’ve had endoscopic surgery. It may help deliver the right radiation dose to different tumor areas while sparing nearby normal tissues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You have confirmed sinus cancer (not melanoma, lymphoma, or sarcoma).
- You had endoscopic sinus surgery with tissue mapping done within 2 months before starting radiation.
- You need radiation treatment (photon or proton) and you did not have chemotherapy before surgery (neoadjuvant chemotherapy).
- Your cancer has not spread to distant parts of the body (no distant metastases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether surgery followed by radiation helps people with a specific type of sinus cancer called adenoid cystic carcinoma that has grown into nearby tissues. It aims to see how well this treatment works and how safe it is.
This study compares surgery alone versus surgery followed by radiation therapy for a rare type of nasal or sinus cancer. It aims to see if adding radiation after surgery helps prevent the cancer from coming back.
This trial tests a combination of an immunotherapy drug (toripalimab) plus chemotherapy before surgery for sinus cancer that has not spread. The goal is to see if this treatment shrinks the tumor so surgery can be more effective.
This trial tests a new way to give radiation therapy for head and neck cancer. By using a special PET scan to guide where higher radiation doses are given, doctors hope to improve treatment while reducing side effects. It is for people whose cancer is not early-stage and who will receive standard radiation therapy.
This trial tests a combination of chemotherapy (docetaxel and cisplatin) plus two immunotherapy drugs before surgery for people with newly diagnosed, locally advanced sinonasal cancer. The goal is to see if this combination helps shrink the tumor and improves the chance of successful surgery.
This trial tests whether adding the immunotherapy drug cemiplimab to standard chemotherapy before surgery helps treat sinonasal squamous cell carcinoma. The goal is to see if this combination reduces tumors more effectively than chemotherapy alone.
Hear when a new Tumor, Solid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.